Viewing Study NCT00628303


Ignite Creation Date: 2025-12-24 @ 7:45 PM
Ignite Modification Date: 2026-01-05 @ 1:52 AM
Study NCT ID: NCT00628303
Status: WITHDRAWN
Last Update Posted: 2012-08-01
First Post: 2008-02-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 3 Trial of the Effect of Motavizumab Prophylaxis on Reduction of Serious Early Childhood Wheezing in Infants
Sponsor: MedImmune LLC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module